hyaluronoglucosaminidase has been researched along with Bladder Cancer in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.00) | 18.7374 |
1990's | 5 (10.00) | 18.2507 |
2000's | 19 (38.00) | 29.6817 |
2010's | 15 (30.00) | 24.3611 |
2020's | 6 (12.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, Y; Hatakeyama, S; Ohyama, C; Suzuki, T; Tobisawa, Y; Yamamoto, H; Yoneyama, MS; Yoneyama, T | 1 |
Ding, X; Fan, J; Fu, Y; Li, X; Li, Z; Wu, T; Zhu, G | 1 |
Azih, I; Baskar, R; Dhir, N; Escudero, DO; Ghosh, S; Hasanali, SL; Hennig, MJP; Hoye, K; Hupe, MC; Jordan, AR; Kavuri, S; Klaassen, Z; Knapp, J; Lokeshwar, BL; Lokeshwar, SD; Lokeshwar, VB; Lopez, LE; Manoharan, M; Morera, DS; Racine, RR; Wang, J; Yates, TJ | 1 |
He, B; Li, J; Li, L; Si, Y | 1 |
Crispen, PL; Dominguez-Gutierrez, PR; Donelan, W; Kusmartsev, S; Kwenda, EP; O'Malley, P | 1 |
Azih, I; Escudero, DO; Ghosh, S; Hasanali, SL; Hennig, M; Hupe, MC; Jordan, AR; Kuczyk, MA; Lokeshwar, VB; Lopez, LE; Merseburger, AS; Morera, DS; Racine, RR; Sarcan, S; Terris, MK; Wang, J; Zhou, M; Zhu, H | 1 |
Badr, S; Barakat, M; Eissa, S; Mohanad, M; Zaghloul, AS | 1 |
Azzazy, HM; Eissa, S; Hamdy, MA; Ismail, MF; Nossier, AI | 1 |
Ayati, M; Bonyadi, M; Hashemi, M; Jamshidian, H; Najjaran Tousi, V; Nowroozi, MR | 1 |
Cheng, D; Han, W; Jiang, M; Song, E; Song, Y; Yang, K | 1 |
Aslan, G; Bozkurt, O; Mammadov, E; Tuna, B; Yorukoglu, K | 1 |
Eissa, S; Essawy, NO; Kotb, YM; Matboli, M | 1 |
Alcaraz, A; Fernández, PL; Ingelmo-Torres, M; Lozano, JJ; Mengual, L; Oosterwijk, E; Ribal, MJ; Schalken, JA; van der Heijden, AG; Witjes, JA | 1 |
Ohyama, C | 1 |
Herman, MP; Karakiewizc, PI; Lotan, Y; Shariat, SF; Svatek, RS | 1 |
Colombo, R | 1 |
Duncan, RC; Garcia, A; Golshani, R; Hennenlotter, J; Jorda, M; Knapp, J; Kramer, MW; Kuczyk, MA; Lokeshwar, VB; Merseburger, AS; Soloway, MS; Stenzl, A | 1 |
Eissa, S; El-Ahmady, O; El-Khouly, IM; El-Zayat, T; Shehata, H; Swellam, M | 1 |
Acosta, K; Ekwenna, OO; Escudero, DO; Golshani, R; Kramer, MW; Lokeshwar, SD; Lokeshwar, VB; Merseburger, AS; Soloway, M | 1 |
Eissa, S; Esmat, M; Hegazy, MG; Salem, AM; Shehata, HH; Zohny, SF | 1 |
Eissa, S; El-Ahmady, O; Esmat, M; Mansour, A; Shehata, H | 1 |
Blewniewski, M; Brys, M; Forma, E; Krzeslak, A; Lipinski, M; Rozanski, W; Wozniak, P | 1 |
Chang, A; Chib, R; Fudala, R; Gryczynski, I; Gryczynski, Z; Mummert, M; Raut, S; Rich, R | 1 |
Duncan, RC; Hautmann, SH; Lokeshwar, VB; Markowitz, S; Posey, JT; Rose, L; Schroeder, GL; Selzer, MG; Soloway, MS; Watson, R | 1 |
Lorenzo Gómez, MF | 1 |
Cheng, RY; Ho, SM | 1 |
Friedrich, MG; Hautmann, S; Huland, H; Jaekel, T; Juenemann, KP; Lokeshwar, VB; Lorenzo Gomez, MF; Michl, U; Schroeder, GL; Toma, M | 1 |
Eissa, S; El-Ahmady, O; El-Khouly, IM; Ghaffer, TM; Kassim, SK; Labib, RA; Razek, OA; Sadek, M | 1 |
Cerwinka, WH; Lokeshwar, BL; Lokeshwar, VB | 1 |
Aboughalia, AH | 1 |
Estrella, V; Gomez, P; Kramer, M; Lokeshwar, BL; Lokeshwar, VB; Lopez, L; Soloway, MS | 1 |
Alvarez, A; Lokeshwar, VB | 1 |
Braun, PM; Eggers, J; Hamann, M; Hautmann, S; Jünemann, KP; Melchior, D; Meyhoff, H; Munk, A; Naumann, M | 1 |
Block, NL; Lokeshwar, VB; Pham, HT | 1 |
Droller, MJ | 1 |
Block, NL; Lokeshwar, VB; Soloway, MS | 1 |
Cherr, GN; Goudarzi, G; Iida, N; Lokeshwar, VB; Selzer, MG; Young, MJ; Yudin, AI | 1 |
Block, NL; Duncan, RC; Lokeshwar, VB; Obek, C; Pham, HT; Soloway, MS; Wei, D; Young, MJ | 1 |
Brown, FM | 1 |
Block, NL; Lokeshwar, VB | 1 |
Getzenberg, RH; Konety, BR | 1 |
Civantos, F; Duncan, RC; Friedrich, MG; Gnann, R; Hautmann, SH; Hellstern, A; Huland, H; Lokeshwar, VB; Schroeder, GL; Soloway, MS | 1 |
Civantos, F; Duncan, RC; Friedrich, MG; Gnann, R; Hautmann, SH; Lokeshwar, VB; Schroeder, GL; Soloway, MS | 1 |
Lokeshwar, VB; Soloway, MS | 1 |
Höbarth, K; Maier, U; Marberger, M | 1 |
Knudson, W; Nemec, RE; Toole, BP | 1 |
Baumgartner, G; Maier, U | 2 |
Barak, F; Eidelman, A; Horn, Y; Walach, N; Waron, M | 1 |
Hukill, PB; Vidone, RA | 1 |
7 review(s) available for hyaluronoglucosaminidase and Bladder Cancer
Article | Year |
---|---|
Glycosylation in bladder cancer.
Topics: Blood Group Antigens; Carbohydrate Metabolism; Galectins; Gangliosides; Glycosphingolipids; Glycosylation; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Membrane Glycoproteins; Proteoglycans; Urinary Bladder Neoplasms | 2008 |
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Topics: Adjuvants, Immunologic; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cysteine Proteinase Inhibitors; Cystoscopy; Fas Ligand Protein; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; In Situ Hybridization, Fluorescence; Inhibitor of Apoptosis Proteins; Lewis X Antigen; Microtubule-Associated Proteins; Nuclear Proteins; Population Surveillance; Prognosis; Sensitivity and Specificity; Survivin; Telomerase; Urinary Bladder Neoplasms | 2008 |
[The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer].
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Female; Flow Cytometry; Follow-Up Studies; Hematuria; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Mass Screening; Neoplasm Proteins; Neoplasm Recurrence, Local; Reagent Kits, Diagnostic; Sensitivity and Specificity; Smoking; Staining and Labeling; Urinalysis; Urinary Bladder Neoplasms; Urine | 2003 |
Bladder cancer biomarkers: current developments and future implementation.
Topics: Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Biomarkers, Tumor; Carcinoembryonic Antigen; Complement Factor H; DNA Methylation; DNA Mutational Analysis; DNA, Neoplasm; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Genomics; Hematuria; Histone Acetyltransferases; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; In Situ Hybridization, Fluorescence; Inhibitor of Apoptosis Proteins; Keratins; Microsatellite Repeats; Microtubule-Associated Proteins; Molecular Diagnostic Techniques; Neoplasm Proteins; Nuclear Proteins; Patient Selection; Predictive Value of Tests; Prognosis; Proteomics; Reagent Kits, Diagnostic; Survivin; Telomerase; Transcription Factors; Urinary Bladder Neoplasms | 2007 |
Urine cytology. It is still the gold standard for screening?
Topics: Antigens, Neoplasm; Antigens, Nuclear; Autoantigens; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Transitional Cell; Diagnosis, Differential; DNA-Binding Proteins; Fibrin Fibrinogen Degradation Products; Flow Cytometry; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mass Screening; Nuclear Proteins; Sensitivity and Specificity; Severity of Illness Index; Telomerase; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Urine | 2000 |
HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.
Topics: Biomarkers, Tumor; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Neoplasm Recurrence, Local; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2000 |
Urine based markers of urological malignancy.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Fibrin Fibrinogen Degradation Products; Flow Cytometry; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Keratins; Nuclear Proteins; Prognosis; Sensitivity and Specificity; Telomerase; Urinary Bladder Neoplasms | 2001 |
2 trial(s) available for hyaluronoglucosaminidase and Bladder Cancer
Article | Year |
---|---|
Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Urinary Bladder Neoplasms | 1989 |
Intravesical chemotherapy of superficial bladder tumors in a controlled trial with cis-platinum versus cis-platinum plus hyaluronidase.
Topics: Aged; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Random Allocation; Urinary Bladder Neoplasms | 1985 |
41 other study(ies) available for hyaluronoglucosaminidase and Bladder Cancer
Article | Year |
---|---|
TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
Topics: Cell Line, Tumor; Cell Membrane; Epithelial-Mesenchymal Transition; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Muscles; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 2022 |
A high sensitivity background eliminated fluorescence sensing platform for hyaluronidase activity detection based on Si QDs/HA-δ-FeOOH nanoassembly.
Topics: Amination; Biosensing Techniques; Enzyme Assays; Fluorescence; Fluorescent Dyes; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Limit of Detection; Male; Quantum Dots; Silicon; Urinary Bladder Neoplasms | 2020 |
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.
Topics: Alternative Splicing; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hyaluronoglucosaminidase; Immunohistochemistry; Mice; Neoplasm Invasiveness; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2020 |
A novel surface-enhanced Raman scattering-based ratiometric approach for detection of hyaluronidase in urine.
Topics: Gold; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Metal Nanoparticles; Particle Size; Silver; Spectrum Analysis, Raman; Surface Properties; Urinary Bladder Neoplasms | 2020 |
Hyal2 Expression in Tumor-Associated Myeloid Cells Mediates Cancer-Related Inflammation in Bladder Cancer.
Topics: Cell Adhesion Molecules; Cell Line, Tumor; Chemokines; Cytokines; GPI-Linked Proteins; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Inflammation; Molecular Weight; Myeloid Cells; Tumor Microenvironment; Urinary Bladder Neoplasms | 2021 |
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Chondroitinases and Chondroitin Lyases; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Mice; Prognosis; Treatment Failure; Urinary Bladder Neoplasms | 2021 |
The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Topics: Base Sequence; DNA Primers; Enzyme-Linked Immunosorbent Assay; Humans; Hyaluronoglucosaminidase; Inhibitor of Apoptosis Proteins; Polymerase Chain Reaction; RNA, Messenger; Survivin; Urinary Bladder Neoplasms | 2013 |
Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer.
Topics: Biomarkers, Tumor; Colorimetry; Gold; Humans; Hyaluronoglucosaminidase; Nanoparticles; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2014 |
Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Transitional Cell; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2014 |
One-step facile synthesis of hyaluronic acid functionalized fluorescent gold nanoprobes sensitive to hyaluronidase in urine specimen from bladder cancer patients.
Topics: Biomarkers, Tumor; Case-Control Studies; Fluorescence; Fluorescence Resonance Energy Transfer; Gold; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Metal Nanoparticles; ROC Curve; Urinary Bladder; Urinary Bladder Neoplasms | 2014 |
Can recurrence and progression be predicted by HYAL-1 expression in primary T1 bladder cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cohort Studies; Disease Progression; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms | 2014 |
Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
Topics: Aged; Biomarkers, Tumor; Epigenesis, Genetic; Female; Humans; Hyaluronoglucosaminidase; Male; MicroRNAs; Middle Aged; RNA, Long Noncoding; Schistosomiasis; Urinary Bladder Neoplasms | 2015 |
A five-gene expression signature to predict progression in T1G3 bladder cancer.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Annexins; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Carcinoma in Situ; Cell Adhesion Molecules; Disease Progression; Female; Gene Expression Profiling; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; Logistic Models; Male; Middle Aged; Prognosis; Protein Serine-Threonine Kinases; Proteoglycans; Retrospective Studies; RNA, Messenger; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2016 |
Editorial comment on: HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
Topics: Biomarkers, Tumor; Disease Progression; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Risk Assessment; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
Topics: Aged; Biomarkers, Tumor; Disease Progression; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Kaplan-Meier Estimate; Logistic Models; Male; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Early Detection of Cancer; Humans; Hyaluronoglucosaminidase; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Middle Aged; RNA; Sensitivity and Specificity; Survivin; Urinary Bladder Neoplasms; Young Adult | 2010 |
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Molecular Diagnostic Techniques; Multigene Family; Prognosis; Recurrence; Urinary Bladder Neoplasms | 2011 |
Urinary retinoic acid receptor-β2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Case-Control Studies; DNA; DNA Methylation; Female; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Promoter Regions, Genetic; Receptors, Retinoic Acid; ROC Curve; Schistosomiasis; Urinary Bladder Neoplasms; Urine | 2012 |
Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; ROC Curve; Schistosomiasis haematobia; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2012 |
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level.
Topics: Aged; Antigens, Neoplasm; Biomarkers, Tumor; Female; Gene Expression Regulation, Enzymologic; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; N-Acetylglucosaminyltransferases; Neoplasm Staging; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; RNA, Messenger; Urinary Bladder Neoplasms | 2012 |
FRET based ratio-metric sensing of hyaluronidase in synthetic urine as a biomarker for bladder and prostate cancer.
Topics: Biomarkers, Tumor; Fluorescein; Fluorescence; Fluorescence Resonance Energy Transfer; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Prostatic Neoplasms; Rhodamines; Urinary Bladder; Urinary Bladder Neoplasms; Urine | 2013 |
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
Topics: Biomarkers, Tumor; Complement Factor H; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 2002 |
A promising bladder cancer detection assay: the HA-HAase test.
Topics: Biomarkers, Tumor; Cytodiagnosis; Enzyme-Linked Immunosorbent Assay; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2004 |
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Topics: Biomarkers, Tumor; Carcinoma, Transitional Cell; Cytodiagnosis; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Male; Middle Aged; Reagent Kits, Diagnostic; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2004 |
Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Humans; Hyaluronoglucosaminidase; Intermediate Filament Proteins; Keratin-20; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2005 |
HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
Topics: Apoptosis; Carcinoma, Transitional Cell; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Extracellular Matrix; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Transfection; Transplantation, Heterologous; Urinary Bladder Neoplasms | 2005 |
Elevation of hyaluronidase-1 and soluble intercellular adhesion molecule-1 helps select bladder cancer patients at risk of invasion.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Hyaluronoglucosaminidase; Intercellular Adhesion Molecule-1; Male; Neoplasm Invasiveness; Predictive Value of Tests; Risk Factors; Urinary Bladder Neoplasms | 2006 |
HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.
Topics: Alternative Splicing; Animals; Apoptosis; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression; Genetic Therapy; Humans; Hyaluronoglucosaminidase; Immunoblotting; Isoenzymes; Mice; Mice, Nude; Neovascularization, Pathologic; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2006 |
[Tumor markers for bladder cancer: up-to-date study by the Kiel Tumor Bank].
Topics: Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Transitional Cell; Cystoscopy; Hematuria; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prospective Studies; Urinary Bladder Neoplasms; Urine | 2007 |
Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Transitional Cell; Disease Progression; Enzyme-Linked Immunosorbent Assay; Humans; Hyaluronoglucosaminidase; Middle Aged; Urinary Bladder; Urinary Bladder Neoplasms | 1997 |
Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Topics: Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female Urogenital Diseases; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male Urogenital Diseases; Sensitivity and Specificity; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells.
Topics: Adult; Aged; Enzyme-Linked Immunosorbent Assay; Humans; Hyaluronoglucosaminidase; Middle Aged; Neoplasm Invasiveness; Tissue Extracts; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1998 |
Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Topics: Aged; Aged, 80 and over; Base Sequence; Humans; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Weight; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Transitional Cell; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2000 |
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].
Topics: Aged; Biomarkers, Tumor; Carcinoma, Transitional Cell; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Neoplasm Staging; Predictive Value of Tests; Reference Values; Urinary Bladder; Urinary Bladder Neoplasms | 2001 |
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Clinical Enzyme Tests; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Middle Aged; Sensitivity and Specificity; Urinary Bladder; Urinary Bladder Neoplasms | 2001 |
Re: Urine based markers of urological malignancy.
Topics: Biomarkers, Tumor; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Urinary Bladder Neoplasms | 2002 |
Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyaluronoglucosaminidase; Male; Mitomycin; Neoplasm Recurrence, Local; Postoperative Care; Time Factors; Urinary Bladder Neoplasms | 1992 |
The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells.
Topics: Binding, Competitive; Carcinoma, Transitional Cell; Cell Membrane; Glycosaminoglycans; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Peptide Hydrolases; Receptors, Cell Surface; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1987 |
Mitomycin C plasma levels after intravesical instillation with and without hyaluronidase.
Topics: Combined Modality Therapy; Drug Combinations; Humans; Hyaluronoglucosaminidase; Mitomycin; Mitomycins; Postoperative Care; Time Factors; Urinary Bladder Neoplasms | 1986 |
Histochemistry of mucus and other polysaccharides in tumors. I. Carcinoma of the bladder.
Topics: Amylases; Carcinoma, Transitional Cell; Glycogen; Glycosaminoglycans; Histocytochemistry; Humans; Hyaluronoglucosaminidase; Mucins; Neuraminidase; Periodic Acid; Polysaccharides; Staining and Labeling; Urinary Bladder Neoplasms | 1965 |